we conclude that the total cy dose , and not bu , is the major factor in the occurrence of vod in bu/cy bmt preparative regimens , and the bucy2 regimen reduces the frequency of vod in autologous and allogeneic graft recipients when compared to cytbi or the bucy4 regimens .
C0010583
cy
C0278611
bu/cy